Rapid attenuation of anti-SARS-CoV-2 antibody in patients with musculoskeletal diseases who reinitiated intensive immunosuppressive therapies after COVID-19.
Masashi OkamotoShoji KawadaNaoko FujiiKazuki MatsukawaHiroshi ShimagamiNachi IshikawaYutaka IshidaYuta YamaguchiKeisuke KawamotoTakayoshi MoritaYasuhiro KatoShinji HigaAtsushi OgataAtsushi KumanogohPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)